MedicGo
Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis.
Metadata
Journaljournal of allergy and clinical immunology-in practice7.574Date
2020 Jun 04
4 months ago
Type
Journal Article
Volume
2020-Jun-04 / :
Author
Padoan R 1, Chieco Bianchi F 2, Marchi MR 2, Cazzador D 3, Felicetti M 1, Emanuelli E 4, Vianello A 2, Nicolai P 4, Doria A 1, Schiavon F 5
Affiliation
  • 2. Respiratory Pathophysiology Division, Department of Cardio-Thoracic-Vascular Sciences, University of Padova, Padova, Italy.
  • 3. Otorhinolaryngology Unit, Department of Neurosciences, University of Padova, Padova, Italy; Section of Human Anatomy, Department of Neurosciences, University of Padova, Padova, Italy.
  • 4. Otorhinolaryngology Unit, Department of Neurosciences, University of Padova, Padova, Italy.
  • 5. Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy. Electronic address: [email protected]
Doi
PMIDMESH
Fav
Like
Download
Share
Export
Cite
7.6
J Allergy Clin Immunol Practjournal of allergy and clinical immunology-in practice
Metadata
LocationUnited States
FromELSEVIER

No Data

© 2017 - 2020 Medicgo
Powered by some medical students